Literature DB >> 9368087

Study to determine the ability of clinical laboratories to detect antimicrobial-resistant Enterococcus spp. in Buenos Aires, Argentina.

S T Cookson1, H Lopardo, M Marin, R Arduino, M J Rial, M Altschuler, L Galanternik, J M Swenson, J I Tokars, W R Jarvis.   

Abstract

Few reports of vancomycin-resistant enterococci have appeared outside the USA. Therefore, we evaluated the ability of five laboratories in Buenos Aires, Argentina, to perform susceptibility testing using the disk diffusion method. Laboratories had difficulty identifying the low- and intermediate-level vancomycin-resistant phenotypes. This suggests that the disk diffusion method used by laboratories abroad may fail to detect some vancomycin-resistant enterococci.

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9368087     DOI： 10.1016/s0732-8893(97)00099-0

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN： 0732-8893            Impact factor:   2.803


  9 in total

1.  The World Health Organization's External Quality Assurance System Proficiency Testing Program has improved the accuracy of antimicrobial susceptibility testing and reporting among participating laboratories using NCCLS methods.

Authors:  Jasmine M Chaitram; Laura A Jevitt; Sara Lary; Fred C Tenover
Journal:  J Clin Microbiol       Date:  2003-06       Impact factor: 5.948

2.  Epidemiology of glycopeptide-resistant enterococci colonizing high-risk patients in hospitals in Johannesburg, Republic of South Africa.

Authors:  A von Gottberg; W van Nierop; A Dusé; M Kassel; K McCarthy; A Brink; M Meyers; R Smego; H Koornhof
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

3.  RIC8 is a guanine-nucleotide exchange factor for Galpha subunits that regulates growth and development in Neurospora crassa.

Authors:  Sara J Wright; Regina Inchausti; Carla J Eaton; Svetlana Krystofova; Katherine A Borkovich
Journal:  Genetics       Date:  2011-07-12       Impact factor: 4.562

4.  Use of molecular and reference susceptibility testing methods in a multicenter evaluation of MicroScan dried overnight gram-positive MIC panels for detection of vancomycin and high-level aminoglycoside resistances in enterococci.

Authors:  Y S Chen; S A Marshall; P L Winokur; S L Coffman; W W Wilke; P R Murray; C A Spiegel; M A Pfaller; G V Doern; R N Jones
Journal:  J Clin Microbiol       Date:  1998-10       Impact factor: 5.948

5.  First report of the isolation of high-level vancomycin-resistant Enterococcus faecium from a patient in Japan.

Authors:  N Fujita; M Yoshimura; T Komori; K Tanimoto; Y Ike
Journal:  Antimicrob Agents Chemother       Date:  1998-08       Impact factor: 5.191

6.  Proficiency of clinical laboratories in Spain in detecting vancomycin-resistant Enterococcus spp. The Spanish VRE Study Group.

Authors:  J Alonso-Echanove; B Robles; W R Jarvis
Journal:  J Clin Microbiol       Date:  1999-07       Impact factor: 5.948

7.  Use of the National Committee for Clinical Laboratory Standards guidelines for disk diffusion susceptibility testing in New York state laboratories.

Authors:  J A Kiehlbauch; G E Hannett; M Salfinger; W Archinal; C Monserrat; C Carlyn
Journal:  J Clin Microbiol       Date:  2000-09       Impact factor: 5.948

8.  Proficiency in detecting vancomycin resistance in enterococci among clinical laboratories in Santiago, Chile.

Authors:  J A Labarca; L C McDonald; M E Pinto; E Palavecino; P González; E Cona; A Fernández; M S Giglio; W R Jarvis
Journal:  Emerg Infect Dis       Date:  1999 Nov-Dec       Impact factor: 6.883

9.  Proficiency of clinical laboratories in and near Monterrey, Mexico, to detect vancomycin-resistant enterococci.

Authors:  L C McDonald; L R Garza; W R Jarvis
Journal:  Emerg Infect Dis       Date:  1999 Jan-Feb       Impact factor: 6.883
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.